Aizawa Y, Konno R, Kawamura A. Spontaneous Repositioning of a Dislodged Atrial Pacemaker Lead. Intern Med. 2022 Jan 1;61(1):127-128.
Tamura Y, Tamura Y, Konami Y, Suzuyama H, Horio E, Yamada M, Sassa T, Taguchi E, Horibata Y, Ideta I, Kawamura A, Sakamoto T. Comparison of left ventricular pacing performance among pre-shaped guidewires designed for transfemoral-approach transcatheter aortic valve implantation. Heart Vessels. 2022 Mar;37(3):460-466.
Tamura Y, Furukawa A, Tamura Y, Yamada K, Taniguchi H, Fukuda K, Kawamura A, Satoh T. Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension. Pulm Circ. 2022 Mar 17;12(1):e12058.
Furukawa A, Tamura Y, Yamada K, Taniguchi H, Ohashi N, Okabe T, Kawamura A. Liver fibrosis index as a novel prognostic factor in patients with pulmonary arterial hypertension. Heart Vessels. 2022 Apr;37(4):601-608.
Toyoda Y, Tateno K, Takeda Y, Kobayashi Y. Significance of mild thrombocytopenia in maintenance hemodialysis patients; a retrospective cohort study. Platelets. 2022 Jul 4;33(5):735-742.
Tamura Y, Tamura Y, Yamada K, Taniguchi H, Iwasawa J, Yada H, Kawamura A. Routine assessment of cardiotoxicity in patients undergoing long-term immune checkpoint inhibitor therapy. Heart Vessels. 2022 Nov;37(11):1859-1865.
Kato TS, Gomi H, Aizawa Y, Kawamura A, Eisen HJ, Hunt SA, Inoue T. Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion. Front Pediatr. 2022 Nov 4;10:935167.
Yamada K, Tamura Y, Taniguchi H, Furukawa A, Iwasawa J, Yada H, Kawamura A, Tamura Y. Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage. Circ Rep. 2022 Oct 4;4(11):526-532.
Tamura Y, Tamura Y, Takemura R, Yamada K, Taniguchi H, Iwasawa J, Yada H, Kawamura A. Longitudinal Strain and Troponin I Elevation in Patients Undergoing Immune Checkpoint Inhibitor Therapy. JACC CardioOncol. 2022 Dec 20;4(5):673-685.
Tomoko S Kato , Harumi Gomi , Howard J Eisen, et al：How to preserve information equity for COVID-19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in
Japan.Clin Transplant. 36(9):e14765.2022.
Tomoko S Kato, Harumi Gomi ,Yoshiyasu Aizawa, et al.：Are we ready for building transition programs for heart transplant recipients in Japan? ‒ Knowing the unique background is the fi rst step for discussion.
Frontiers in Pediatrics .10:935167.2022.
Toshio Nagai：Systemic Transfusion of Human Umbilical Cord-Derived Mesenchymal Stromal Cells - Toward Less Invasive and More Effective Cell Therapy for Severe Peripheral Arterial DiseaseCirc J. 24;87(3):421-
423.2023.
Ryoma Fukuoka , Yoshitake Yamada , Masaharu Kataoka, et al.：Estimating right atrial pressure using upright computed tomography in patients with heart failure.Eur Radiol.33(6):4073-4081.Epub.2022.
Toshiaki Suzuki, Tomoko S Kato, Tenjin Nishikura, et al.：Multiple Micro-Neo-Vessels Detected by Optical Coherence Tomography (OCT) May Predict a Progression of Cardiac Allograft Vasculopathy in Posttransplant
Recipients.Korean Circ J. 52(5):398-400.2022.
Yukiko Toyoda, Kaoru Tateno, Yorinobu Takeda, et al.：Significance of mild thrombocytopenia in maintenance hemodialysis patients; a retrospective cohort study.Platelets. 33(5):735-742.2022.
加藤倫子、相澤義泰、杉村宏一郎 ほか：心疾患を伴う周産期の薬物治療(Immunosuppressive Therapy during Pregnancy and Perinatal Management in Heart Transplant Recipients)(英語)、第87回日本循環器学会学術集会、2023年3月
